<p></p><p><span>Fatigue is a major symptom in patients with multiple sclerosis (pwMS) and is mainly responsible for unemployment, early retirement but also social withdrawal. This book combines reporting of actually existing scientific knowledge with guidance for clinical practice. As such the book
Fatigue in Multiple Sclerosis: Background, Clinic, Diagnostic, Therapy
â Scribed by Iris-Katharina Penner (editor)
- Publisher
- Springer
- Year
- 2023
- Tongue
- English
- Leaves
- 196
- Edition
- 1st ed. 2023
- Category
- Library
No coin nor oath required. For personal study only.
⌠Synopsis
Fatigue is a major symptom in patients with multiple sclerosis (pwMS) and is mainly responsible for unemployment, early retirement but also social withdrawal. This book combines reporting of actually existing scientific knowledge with guidance for clinical practice. As such the book helps health care professionals in all countries to better understand fatigue symptoms but also to help patients to better cope with them.Â
Â
⌠Table of Contents
Preface
Contents
Part I: Background
On the History of Fatigue
References
Further Reading
Definitions, Epidemiology, and Etiological Factors
1 Definitions and Terminology
2 Prevalence and Significance of Fatigue
3 Demographic and Clinical Factors
4 Etiological Factors
4.1 Personality Traits
4.2 Autonomous Regulation
4.3 Endocrine Factors
4.4 Proinflammatory Cytokines
4.5 Attention Deficit Disorder
4.6 Structural and Functional Brain Changes
4.7 Summary of the Considerations on the Etiological Factors
References
Pathophysiology and Differentiation from Other Symptoms and Diseasess
1 Introduction
2 Primary Fatigue
2.1 Structural and Functional Imaging
2.2 Neurophysiological Findings
2.2.1 Electroencephalography
2.2.2 Transcranial Magnetic Stimulation
3 Secondary Fatigue
3.1 Sleep Disorders
3.2 Other Causes
4 Summary and Outlook
References
Immunopathology and Pathogenesis
1 Introduction
2 Immunopathology and Pathomorphological Changes in MS
2.1 Demyelination
2.2 Gray Matter Lesions
2.3 Axonal Lesions and Neurodegeneration
3 Inflammatory Mediators and Fatigue in MS
4 Pathological Patterns of Damage and Fatigue in MS
5 Neuroendocrine Regulatory Disorders in MS
6 Multidimensionality of Fatigue and Damage Processes in MS
7 Summary
References
Part II: Clinic
Motor Performance Fatigability in MS
1 Introduction
2 Clinician and Patient Perspective
3 Gait-Related Motor Performance Fatigability
3.1 Linear Approaches for Gait Analysis
3.1.1 Distance Walked Index
3.1.2 Deceleration Index
3.2 Nonlinear Approaches for Gait Analysis
3.2.1 Local Dynamic Stability
3.2.2 Fatigue Index Kliniken Schmieder
4 Motor Performance Fatigability and Perceived Fatigability
5 Interactions between Sustained Cognitive or Motor Activity and Performance Fatigability
6 Motor Performance Fatigability and Trait Fatigue
7 Motor Performance Fatigability and Trait Self-Control
8 Pharmacological and Non-pharmacological Treatment of Motor Performance Fatigability
9 Summary
References
Cognitive Fatigue
1 Introduction
2 Definition of Cognitive Fatigue
3 Neuroanatomical Correlates of Cognitive Fatigue
4 Cognitive Fatigue and Cognition
5 The Role of Attention in the Diagnosis of Fatigue
6 Summary
References
Personality Factors and Motivation
1 Introduction
2 Personality and MS
3 Personality Trait Assessment Instruments
4 Motivation
5 Behavioral Aspects: Coping and Disease Management
6 Conclusion
References
Fatigue and Depression
1 Introduction
2 Symptom Overlap Between Fatigue and Depression
3 Depression and Fatigue in MS from a Diagnostic Perspective
4 Depression and Fatigue in MS from a Research Perspective: Pathophysiology
5 Depression and Fatigue in MS from a Therapeutic Perspective
6 Summary
References
Sleep and Wake Disturbances
1 Epidemiology
1.1 Sleep Diagnostics
2 Sleep-Wake Disorders
2.1 Insomnia
2.2 Restless Legs Syndrome
2.3 Sleep-Disordered Breathing
2.4 Excessive Daytime Sleepiness and Fatigue
3 Nocturia
3.1 Other Sleep and Wake Disturbances
References
Part III: Diagnostics
Clinical Assessment Tools for Fatigue
1 Introduction
2 Neurological Interview
3 Fatigue Diaries
4 Fatigue Questionnaires
5 Neurophysiological Possibilities of Detection
6 Summary
References
Neuroimaging and Fatigue
1 Macrostructural Imaging Correlates of Primary Fatigue
1.1 Relevance of Inflammatory White Matter Lesions
1.2 Changes in Global and Regional Brain Volume
2 Microstructural Imaging Correlates of Primary Fatigue
3 Functional Imaging Correlates of Primary Fatigue
4 Functional Imaging Correlates of Fatigability
5 Secondary Fatigue and Imaging Findings
6 Summary and Outlook
References
Electrophysiology and Fatigue
1 Introduction
1.1 Fatigue and Exhaustibility
1.2 Heterogeneity of Studies on Exhaustibility
1.3 Peripheral and Central Fatigue
1.4 Electrophysiological Methods for the Investigation of Fatigue
2 Electrophysiological Findings in Healthy Subjects
2.1 Corticospinal Excitability
2.2 Intracortical Excitability
2.3 Cortical Silent Period
2.4 Potential Influencing Factors
3 Electrophysiological Findings in MS Patients
3.1 Corticospinal Excitability
3.2 Intracortical Excitability
3.3 Cortical Silent Period (CSP)
3.4 Event-Related Potentials
3.5 âEvent-Related Desynchronizationâ
3.6 High Frequency Oscillations
3.7 Fronto-Thalamic Networks
4 Effects of Therapeutic Approaches on Electrophysiological and Clinical Parameters in MS Patients
4.1 Pharmacological Therapeutic Approaches
4.2 External Brain Stimulation
4.2.1 Transcranial Direct Current Stimulation (tDCS)
4.2.2 Repetitive Transcranial Magnetic Stimulation (rTMS) and Intermittent Theta Burst Stimulation (iTBS)
5 Summary
References
Expert Opinion and Medicolegal Assessment
1 Basics of Expert Opinions
2 Objectification of Fatigability
2.1 Fundamental Aspects
2.2 Value of Questionnaires
2.3 Objectification of Cognitive Fatigability
2.4 Objectification of Motor Fatigability
2.4.1 Upper Extremities
2.4.2 Lower Extremities
3 Symptom Validity Assessment
3.1 Basics
3.2 Fatigue-Related Symptom Validity Assessment
3.2.1 Medical History
3.2.2 Cognitive Fatigability
3.2.3 Motor Fatigability
3.2.4 Clinical Symptom Validation
4 Assessing Occupational Capacity
4.1 Quantification of Fatigability According to ICF
5 Assessing Driving Ability
5.1 Basics
5.2 Driving with Fatigue Symptoms
5.2.1 Orientation towards Self-Perception
5.2.2 Orientation towards Occupational Capacity
5.2.3 Orientation to Daytime Sleepiness
References
Part IV: Therapy
Disease Modifying Immunotherapies and Fatigue
1 Immunotherapies for Mild/Moderate Forms of MS
1.1 Interferons
1.2 Glatiramer Acetate
1.3 Dimethyl Fumarate
1.4 Teriflunomide
2 Immunotherapies for (Highly) Active Forms of MS
2.1 Fingolimod
2.2 Cladribine
2.3 Natalizumab
2.4 Alemtuzumab
2.5 Ocrelizumab
2.6 Rituximab
3 Classic Immunosuppressants
4 New Immunotherapeutics in MS
4.1 Siponimod
4.2 Ozanimod
4.3 Ponesimod
5 Summary
References
Symptomatic Drug Treatment of Fatigue
1 Introduction
2 Symptomatic Therapeutic Approaches
3 Drug Treatment Approaches
4 Immunological Treatment Approaches
4.1 Cytokines
5 Immunosuppressive Therapies
5.1 Cortisone
6 Endocrine Treatment Approaches
6.1 Hydrocortisone/Fludrocortisone
6.2 ACTH
6.3 Alfacalcidol
7 Neurotransmitter-Oriented Treatment Approaches
7.1 Amantadine
7.2 Ketamine
7.3 Modafinil
7.4 Ondansetron
8 Treatment Approaches with Channel Blockers
8.1 Fampridine (Syn. 4-Aminopyridine)
9 Treatment Approaches with Stimulants
9.1 L-Amphetamine
9.2 Methylphenidate
10 Antidepressant Therapy Methods
10.1 Selective Serotonin Reuptake Inhibitors (SSRI)
11 Other Drug Therapy Approaches
11.1 Ginseng
11.2 N-Acetylcysteine
11.3 Pemoline
11.4 Carnitine
References
Non-drug Treatment Approaches and Neurorehabilitation
1 Introduction
2 Exercise Therapy
3 Cryotherapy
4 Training and Empowerment
5 Cognitive Behavioral Therapy
6 Nutrition
7 Non-invasive Brain Stimulation
8 Neurorehabilitation
9 Summary
References
đ SIMILAR VOLUMES
<b>Multiple Sclerosis: a complex disease requiring sophisticated management <br /></b>Multiple Sclerosis poses labyrinthine challenges. There is no blood test to rely on for diagnosis; clinical acumen is essential. Yet an effective diagnosis only takes you part of the way: treatment offers further e
This practical guide for physicians and other health care professionals discusses the impact of fatigue on the individual with MS, the potential etiologies underlying MS-related fatigue, its work up and diagnosis, and pharmacologic and nonpharmacologic management strategies. <P>Fatigue is perhap
Managing multiple sclerosis, with all the associated problems of a progressive chronic disease, requires special knowledge on the part of the clinician. From which drugs to prescribe for an acute attack, to the use of new drugs available to help control the disease process, to managing the myriad of
This reference presents cutting-edge basic and clinical research on all forms of interferon (IFN) involvement in the management of multiple sclerosis (MS)-detailing topics from IFN-receptor molecular interactions to synergy and interference with other agents such as cytotoxic drugs and chemotherapy.